| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 19 |
| 1 | ACETAMINOPHEN 500MG | 15 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 15 |
| 3 | PAIN RELIEVER | 15 |
| 4 | PEMBROLIZUMAB | 12 |
| 5 | ASPIRIN | 11 |
| 6 | ASPIRIN 325 MG | 11 |
| 7 | ASPIRIN 81 MG | 11 |
| 8 | LEVOTHYROXINE SODIUM | 11 |
| 9 | ERGOCALCIFEROL | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALQUETAMAB-TGVS | 10 | 0.0067 |
| 1 | USTEKINUMAB-STBA | 1 | 0.0027 |
| 2 | GLYCOPYRRONIUM | 3 | 0.0019 |
| 3 | SILICON DIOXIDE | 1 | 0.0016 |
| 4 | STANNOUS FLUORIDE | 1 | 0.0014 |
| 5 | PEMIGATINIB | 1 | 0.0012 |
| 6 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| 7 | NERANDOMILAST | 1 | 0.0006 |
| 8 | CABAZITAXEL | 2 | 0.0006 |
| 9 | PRALSETINIB | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 4 | Radioligand Therapeutic Agent [EPC] | 3 | 0.0002 |
| 5 | Antimalarial [EPC] | 2 | 0.0002 |
| 6 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 7 | Bismuth [EPC] | 1 | 0.0002 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 | 0.0002 |
| 9 | Somatostatin Analog [EPC] | 1 | 0.0001 |